Hedge Fund Activism Changes Corporate R&D Investment Time HorizonMark Melin
It understates the situation to simply state the pace of shareholder activism has increased recently. What we are witnessing is “activism on steroids,” says a new academic white paper that considers the impact of activist investors on publicly traded stocks. The study considers the negative impacts on research and development and shortening the corporate investment time horizon.
Impact of shareholder activism on publically traded stocks
While the impact on the stock price in the . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.